News
Is Canopy Growth Stock a Buy?
Recently, Martha Stewart, the entertainment and lifestyle icon, launched a new set of cannabis-infused oils and edibles bearing her personal brand. Rather than targeting people that need medicinal
2 Dirt-Cheap Robinhood Stocks That Could Skyrocket
Robinhood investors love betting on beaten-down stocks with the potential to bounce back. It's a risky strategy that can deliver outsized returns if things go as planned. Ford Motor (NYSE: F) and
Apple's Big iOS14 Update Could Wound These 2 Tech Giants
Back in June, Apple (NASDAQ: AAPL) announced it would require users to opt-in for ad tracking features for every app in iOS 14. The announcement immediately sparked complaints from advertisers that
The 3 Safest Stocks to Buy With Your Stimulus Money
It's not often that you get a Christmas gift from Uncle Sam. Now that a $600 stimulus check could be on the way, it's a great time to pick a few stalwart stocks to shore up your portfolio's
This Was My Single Worst Investment in 2020
Perspective has a lot to do with how investors view this year. You're either thrilled to see 2020 come to a close, or you're sad to see such an impressive year for high-growth stocks end.
The
3 Investing Myths You Can't Afford to Believe
If your goal is to grow near-term as well as long-term wealth, investing your money could be your ticket to it. If you're new to investing, you may believe certain myths that could come back to bite
Here's a Cancer-Killing Stock to Buy for 2021
In our bodies we have cancer-killer cells called "natural killer" cells, or NK cells. These cells are part of our innate immune system. When an NK cell comes across a malign cancer cell in the
If You're Retired, Consider Buying These 3 Stocks in 2021
As a retiree, your primary goal is to set up safe, steady, and secure income streams that can not only cover your living expenses comfortably but also provide a buffer for emergencies. Investing in
Why Qualcomm Is a Dividend Investor's Dream
Investors have become accustomed to treating Qualcomm (NASDAQ: QCOM) as they would any other stock in big tech. These investors may not see it as a dividend stock, let alone a dividend investor's
Will Tesla Deliver 500,000 Vehicles This Year?
Despite factory shutdowns earlier this year as Tesla (NASDAQ: TSLA) dealt with the coronavirus pandemic, the electric-car maker's shares have soared in 2020. The growth stock is up nearly 700% year
3 Dividend Stocks That Are Perfect for Retirement
Dividend stocks are a natural choice for a retirement portfolio. But picking the right ones isn't always easy. You've got to be strategic with your selections.
The highest yield dividend stocks are
3 Reasons I'm Buying Netflix Stock
When it comes to identifying stocks for potential investment, I focus primarily on qualitative factors. Before I even look at the valuation, the business needs to make sense to me, and it must have
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
Inovio Pharmaceuticals (NASDAQ: INO) has given different groups of investors some wildly varying stock performances this year. If you bought its shares at the beginning of 2020, your investment is
Here's What A Doctor Thinks Are The Biggest Vaccination Challenges
Will consumers one day have a choice of which coronavirus vaccine they receive? Will the market for vaccines be overly complicated once other players join Moderna (NASDAQ: MRNA) and Pfizer (NYSE:
Can You Retire a Millionaire Saving $500 per Month?
There are more retirement millionaires than ever before. In the third quarter of 2020, approximately 262,000 people had at least $1 million in their 401(k), according to research from Fidelity
Does 1+1=3 for This Merger Between Two Cannabis Heavyweights?
On Dec. 16, Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY) announced plans to merge in an all stock transaction that would create a company with pro forma combined revenues of almost $685 million
Danger Lurks for These 3 High-Yield Dividend Stocks
High-yield dividends by themselves don't necessarily scream risk, but high-yielding dividends in companies that are having financial difficulties do. That's why it makes sense to look at a company's
If You Invested $1,000 in Novavax in January, This Is How Much Money You'd Have Now
Novavax (NASDAQ: NVAX) represents the dream investment. At the beginning of the year, you invest in an interesting clinical-stage biotech trading at less than $5 a share. Then, in a matter of
Why Is Everybody Talking About Novavax Stock?
In 2020, Novavax (NASDAQ: NVAX) jumped from obscurity and took investors on the thrill ride of the year. Shares of this tiny biotech skyrocketed from $4 in January to $117 in December. That spells
Beyond Pfizer and Moderna: What Investors Need to Know About the Next COVID Vaccines in The Pipeline
Earlier this month, coronavirus vaccines from Moderna (NASDAQ: MRNA) and the team of Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) received Emergency Use Authorization from the U.S. Food and Drug
Here's When to Expect Your $600 Second Stimulus Check
As part of the $900 billion COVID-19 relief package that was just passed -- formally known as the Coronavirus Response and Relief Supplemental Appropriations Act -- Congress authorized a second
5 Facts That Will Help You Sleep Better Next Time the Stock Market Crashes
We all like to think we'll stay calm and collected the next time the stock market crashes. Better yet, we promise ourselves we won't pass up the opportunity. Instead, we'll invest even more.
But
3 Best Robinhood Stocks to Buy for 2021
Robinhood investors have a reputation for picking high-risk, high-reward stocks. To be fair, you'll find quite a few of them on the list of the platform's 100 most popular stocks. But others don't
The Top 3 Marijuana Stocks to Buy in 2021
Global marijuana sales will soar to $200 billion within the next decade, according to investment bank Stifel. Fortunes will be made by investors who are able to identify the companies best
Now Could Be the Perfect Time to Buy This Under-the-Radar COVID Vaccine Stock
You might be kicking yourself that you didn't buy shares of coronavirus vaccine leader Moderna (NASDAQ: MRNA) earlier this year. The biotech's vaccine is now on the market in the U.S. and its market